Thermoluminescent dosimeters (TLD-100) for absorbed dose measurements in alpha-emitting radionuclides

被引:0
|
作者
White, Andrew J. [1 ]
Jollota, Sean P. [1 ]
Hammer, Cliff G. [1 ]
Khan, Ahtesham U. [1 ,2 ]
DeWerd, Larry A. [1 ]
Culberson, Wesley S. [1 ]
机构
[1] Univ Wisconsin, Madison Sch Med & Publ Hlth, Dept Med Phys, 1111 Highland Ave, Madison, WI 53705 USA
[2] Northwestern Mem Hosp, Dept Radiat Oncol, 250 E Huron St, Chicago, IL 60611 USA
关键词
Thermoluminescent dosimetry; TLD-100; Alpha-emitting radionuclides; Polonium-210; TL-LET RESPONSE; EFFICIENCY; LIF; THERAPY;
D O I
10.1016/j.apradiso.2024.111307
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Early works that used thermoluminescent dosimeters (TLDs) to measure absorbed dose from alpha particles reported relatively high variation (10%) between TLDs, which is undesirable for modern dosimetry applications. This work outlines a method to increase precision for absorbed dose measured using TLDs with alpha-emitting radionuclides by applying an alpha-specific chip factor (CF) that individually characterizes the TLD sensitivity to alpha particles. Variation between TLDs was reduced from 21.8% to 6.7% for the standard TLD chips and 7.9% to 3.3% for the thin TLD chips. It has been demonstrated by this work that TLD-100 can be calibrated to precisely measure the absorbed dose to water from alpha-emitting radionuclides.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Comparison of the response of BeOSL and TLD-100 passive personal dosimeters with four detectors
    Oliver, L.
    Candela, C.
    Palma, J. D.
    Pujades, M. C.
    Soriano, A.
    Alabau, J.
    Martinez, J.
    Mestre, V.
    Ruiz, J. C.
    Vilar, J.
    Llorca, N.
    2016 GLOBAL MEDICAL ENGINEERING PHYSICS EXCHANGES/PAN AMERICAN HEALTH CARE EXCHANGES (GMEPE/PAHCE), 2016,
  • [32] Absorbed dose rates and biological consequences of discrete alpha-emitting particles embedded in tissue
    Kaltofen, Marco
    Plato, Phillip
    APPLIED RADIATION AND ISOTOPES, 2024, 210
  • [33] ESTIMATION OF EFFECTIVE GAMMA-ENERGY BY DIFFERENTIAL RESPONSES OF TLD-100 AND TLD-200 DOSIMETERS
    MOMENI, MH
    JOW, N
    COUNTIS, T
    WORDEN, L
    BRADLEY, E
    HEALTH PHYSICS, 1975, 28 (06): : 809 - 812
  • [34] Alpha-Emitting Radionuclides: Current Status and Future Perspectives
    Miederer, Matthias
    Benesova-Schaefer, Martina
    Mamat, Constantin
    Kaestner, David
    Pretze, Marc
    Michler, Enrico
    Brogsitter, Claudia
    Kotzerke, Jorg
    Kopka, Klaus
    Scheinberg, David A.
    McDevitt, Michael R.
    PHARMACEUTICALS, 2024, 17 (01)
  • [35] Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides
    Li, Wei Bo
    Bouvier-Capely, Celine
    Vargas, Clarita Saldarriaga
    Andersson, Michelle
    Madas, Balazs
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2022, 61 (04) : 579 - 596
  • [36] The potential for Cerenkov luminescence imaging of alpha-emitting radionuclides
    Ackerman, N. L.
    Graves, E. E.
    PHYSICS IN MEDICINE AND BIOLOGY, 2012, 57 (03): : 771 - 783
  • [37] Chemical and Radiochemical Considerations in Radiolabeling with alpha-Emitting Radionuclides
    Wilbur, D. Scott
    CURRENT RADIOPHARMACEUTICALS, 2011, 4 (03) : 214 - 247
  • [38] RADIOLOGICAL HAZARDS OF WASTE CONTAINING ALPHA-EMITTING RADIONUCLIDES
    RODGERS, JC
    NUCLEAR AND CHEMICAL WASTE MANAGEMENT, 1983, 4 (01): : 95 - 101
  • [39] Comparison of alpha-emitting radionuclides for cancer treatment.
    Fisher, DR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U933 - U933
  • [40] Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides
    Mirzadeh, Saed
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2019, 50 (04) : S21 - S25